.Pharmacolibrary.Drugs.ATC.N.N06AB08

Information

name:Fluvoxamine
ATC code:N06AB08
route:oral
n-compartments1

Fluvoxamine is a selective serotonin reuptake inhibitor (SSRI) primarily used to treat major depressive disorder and obsessive-compulsive disorder (OCD). It is approved and commonly used today in various countries for these indications.

Pharmacokinetics

Pharmacokinetic parameters reported for healthy adult volunteers after single oral dose administration.

References

  1. Zang, YN, et al., & Ruan, CJ (2024). Population pharmacokinetics of olanzapine in pediatric patients with psychiatric disorders. Expert opinion on drug metabolism & toxicology 20(8) 827–840. DOI:10.1080/17425255.2024.2380472 PUBMED:https://pubmed.ncbi.nlm.nih.gov/39010781

  2. DeVane, CL, & Gill, HS (1997). Clinical pharmacokinetics of fluvoxamine: applications to dosage regimen design. The Journal of clinical psychiatry 58 Suppl 5 7–14. PUBMED:https://pubmed.ncbi.nlm.nih.gov/9184622

  3. de Leon, J, et al., & Ruan, CJ (2020). Using therapeutic drug monitoring to personalize clozapine dosing in Asians. Asia-Pacific psychiatry : official journal of the Pacific Rim College of Psychiatrists 12(2) e12384–None. DOI:10.1111/appy.12384 PUBMED:https://pubmed.ncbi.nlm.nih.gov/32119764

Revisions

Generated at 2025-07-21T18:21:10Z by OpenModelicaOpenModelica 1.25.1 using GenerateDoc.mos